ACADIA Pharmaceuticals Inc. vs Agnico Eagle Mines Ltd — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Agnico Eagle Mines Ltd trades at $184.84 (market cap $92.01B). The key difference: Agnico Eagle Mines Ltd is far larger — about 18.1× ACADIA Pharmaceuticals Inc.'s market cap, and Agnico Eagle Mines Ltd pays a 0.99% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | AEM | |
|---|---|---|
Market Cap | $5.07B | $92.01B |
Sector | Health | Basic Materials |
52-Week High | $29.41 | $252.19 |
52-Week Low | $20.06 | $130.23 |
Enterprise Value | $4.19B | $88.85B |
Dividend Yield | — | 0.99% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →